Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Sexually Transmitted Diseases

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 101 articles: HTML format

Single Articles

July 2022
1. BABALOLA CM, Siebert JC, Kallapur SG, Maecker HT, et al
   Discrete Plasma Cytokine Profiles among Pregnant Women in Botswana by Chlamydia trachomatis infection, HIV status, and Gestational age.
   J Infect Dis. 2022 Jul 25. pii: 6649668. doi: 10.1093.
   PubMed    
   
   
   June 2022
2. DICKEY BL, Giuliano AR, Sirak B, Abrahamsen M, et al
   Control of Epstein-Barr virus (EBV) in the oral cavity is associated with persistence of oral HPV 16/18 among men from the HPV Infection in Men (HIM) Study.
   J Infect Dis. 2022 Jun 9. pii: 6604966. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2022
3. WEI F, Xia N, Ocampo R, Goodman MT, et al
   Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies.
   J Infect Dis. 2022 Mar 23. pii: 6553063. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2022
4. JOHNSON RM, Asashima H, Mohanty S, Shaw AC, et al
   Combining cellular immunology with RNAseq to identify novel chlamydia T cell subset signatures.
   J Infect Dis. 2022 Feb 16. pii: 6529704. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2022
5. LAURIE C, El-Zein M, Tota J, Khosrow-Khavar F, et al
   Efficacy of a carrageenan gel in increasing clearance of anal HPV infections in men: interim analysis of a double-blind randomized controlled trial.
   J Infect Dis. 2022 Jan 28. pii: 6516990. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. ZHANG Y, D'Souza G, Fakhry C, Bigelow EO, et al
   Oral HPV associated with differences in oral microbiota beta diversity and microbiota abundance.
   J Infect Dis. 2022 Jan 17. pii: 6509880. doi: 10.1093.
   PubMed     Abstract available
   
   
   December 2021
7. LEWIS LA, Gulati S, Zelek WM, Morgan BP, et al
   Efficacy of an experimental gonococcal lipooligosaccharide mimitope vaccine requires terminal complement.
   J Infect Dis. 2021 Dec 31. pii: 6491069. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. BRUNHAM RC
   Problems with Understanding Chlamydia trachomatis Immunology.
   J Infect Dis. 2021 Dec 17. pii: 6469012. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. HUI BB, Padeniya TN, Rebuli N, Gray RT, et al
   A gonococcal vaccine has the potential to rapidly reduce the incidence of Neisseria gonorrhoeae infection among urban men who have sex with men.
   J Infect Dis. 2021 Dec 11. pii: 6459455. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. CHRISTENSEN H, Vickerman P
    Gonococcal vaccines for controlling Neisseria gonorrhoeae in men who have sex with men: a promising game-changer.
    J Infect Dis. 2021 Dec 11. pii: 6459454. doi: 10.1093.
    PubMed    
    
    
    October 2021
11. LIU C, Hufnagel K, O'Connell CM, Goonetilleke N, et al
    Reduced Endometrial Ascension and Enhanced Reinfection Associated with IgG Antibodies to Specific Chlamydia trachomatis Proteins in Women at Risk for Chlamydia.
    J Infect Dis. 2021 Oct 5. pii: 6381657. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
12. MARKOWITZ LE, Schiller JT
    Human Papillomavirus Vaccines.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
13. MATTHIAS KA, Connolly KL, Begum AA, Jerse AE, et al
    Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.
    J Infect Dis. 2021 Sep 8. pii: 6366578. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
14. RAHMAN KS, Kaltenboeck B
    Multipeptide Assays for Sensitive and Differential Detection of Anti-Chlamydia Trachomatis Antibodies.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
15. PAAVONEN J, Turzanski Fortner R, Lehtinen M, Idahl A, et al
    Chlamydia trachomatis, Pelvic Inflammatory Disease, and Epithelial Ovarian Cancer.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
16. DARVILLE T
    Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
17. XU SX, Gray-Owen SD
    Gonococcal Pelvic Inflammatory Disease: Placing Mechanistic Insights Into the Context of Clinical and Epidemiological Observations.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
18. HORNER PJ, Flanagan H, Horne AW
    Is There a Hidden Burden of Disease as a Result of Epigenetic Epithelial-to-Mesenchymal Transition Following Chlamydia trachomatis Genital Tract Infection?
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
19. ZHENG X, Zhong W, O'Connell CM, Liu Y, et al
    Host Genetic Risk Factors for Chlamydia trachomatis-Related Infertility in Women.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
20. CONNOLLY KL, Pilligua-Lucas M, Gomez C, Costenoble-Caherty AC, et al
    Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
21. MITCHELL CM, Anyalechi GE, Cohen CR, Haggerty CL, et al
    Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
22. NAGARAJAN UM, Cho C, Gyorke CE, Nagarajan S, et al
    Tumor Necrosis Factor Alpha-Induced Interleukin-1 Alpha Synthesis and Cell Death Is Increased in Mouse Epithelial Cells Infected With Chlamydia muridarum.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
23. HORNER PJ, Anyalechi GE, Geisler WM
    What Can Serology Tell Us About the Burden of Infertility in Women Caused by Chlamydia?
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
24. RUSSELL MW
    Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
25. HILLIER SL, Bernstein KT, Aral S
    A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
26. DAVIS GS, Horner PJ, Price MJ, Mitchell HD, et al
    What Do Diagnoses of Pelvic Inflammatory Disease in Specialist Sexual Health Services in England Tell Us About Chlamydia Control?
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
27. MAN I, Vanska S, Lehtinen M, Bogaards JA, et al
    Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
    J Infect Dis. 2021;224:481-491.
    PubMed     Abstract available
    
    
    July 2021
28. WINER RL, Lin J, Querec TD, Unger ER, et al
    Effectiveness Of Human Papillomavirus (HPV) Vaccination Against Penile Hpv Infection In Men Who Have Sex With Men And Transgender Women.
    J Infect Dis. 2021 Jul 28. pii: 6329629. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
29. VAHLE K, Gargano JW, Lewis RM, Querec TD, et al
    Prevalence of human papillomavirus among females older than recommended age for vaccination by birth cohort, United States 20032016.
    J Infect Dis. 2021 Jun 23. pii: 6308446. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. BRAUNSTEIN SL, Slutsker JS, Lazar R, Shah D, et al
    Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City.
    J Infect Dis. 2021 Jun 16. pii: 6301136. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2021
31. RAVINDRAN J, Richardson B, Kinuthia J, Unger JA, et al
    Chlamydia, gonorrhea, and incident HIV infection during pregnancy predict preterm birth despite treatment.
    J Infect Dis. 2021 May 23. pii: 6282455. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. SUNDSTROM K, Dillner J
    How Many Human Papillomavirus Types Do We Need to Screen For?
    J Infect Dis. 2021;223:1510-1511.
    PubMed    
    
    
    
33. HOES J, King AJ, Schurink-van 't Klooster TM, Berkhof PJ, et al
    Vaccine effectiveness following routine immunization with bivalent HPV vaccine: Protection against incident genital HPV infections from a reduced-dosing schedule.
    J Infect Dis. 2021 May 8. pii: 6272563. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2021
34. PAUL P, Hammer A, Rositch AF, Burke AE, et al
    Rates of New Human Papillomavirus Detection and Loss of Detection in Middle-aged Women by Recent and Past Sexual Behavior.
    J Infect Dis. 2021;223:1423-1432.
    PubMed     Abstract available
    
    
    
35. CUSTER J, Patel R, Delclos GL, DeSantis SM, et al
    Concurrent and Concordant Oral and Genital High-Risk Human Papillomavirus in the United States: Results from the National Health and Nutrition Examination Survey.
    J Infect Dis. 2021;223:1400-1409.
    PubMed     Abstract available
    
    
    
36. KENYON C
    Dual azithromycin/ceftriaxone therapy for gonorrhoea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold.
    J Infect Dis. 2021 Apr 2. pii: 6209316. doi: 10.1093.
    PubMed    
    
    
    March 2021
37. LIN HY, Fu Q, Kao YH, Tseng TS, et al
    Antioxidants Associated with Oncogenic HPV Infection in women.
    J Infect Dis. 2021 Mar 18. pii: 6178356. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. WANG K, Dropulic L, Bozekowski J, Pietz HL, et al
    Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine.
    J Infect Dis. 2021 Mar 15. pii: 6170962. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
39. BANHART S, Selb R, Oehlmann S, Bender J, et al
    The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae, Germany, 2018.
    J Infect Dis. 2021 Feb 16. pii: 6138844. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2021
40. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. GAISA MM, Sigel KM, Deshmukh AA, Lenskaya V, et al
    Comparing Anal Cancer Screening Algorithms Using Cytology and HPV DNA Testing in Three High-risk Populations.
    J Infect Dis. 2021 Jan 3. pii: 6060069. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2020
42. SIERRA MS, Tsang SH, Hu S, Porras C, et al
    Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT).
    J Infect Dis. 2020 Dec 16. pii: 6039229. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. EL-ZEIN M, Khosrow-Khavar F, Burchell AN, Tellier PP, et al
    Association of serum 25-hydroxyvitamin D with prevalence, incidence, and clearance of vaginal HPV infection in young women.
    J Infect Dis. 2020 Dec 11. pii: 6030992. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2020
44. POYNTEN IM, Jin F, Garland SM, Hillman RJ, et al
    HIV, immune dysfunction and the natural history of anal high-risk human papillomavirus infection in gay and bisexual men.
    J Infect Dis. 2020 Nov 21. pii: 5998258. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. YAN Y, Zhang H, Jiang C, Ma X, et al
    Human papillomavirus prevalence and integration status in tissue samples of bladder cancer in Chinese population.
    J Infect Dis. 2020 Nov 18. pii: 5986718. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. TROJA C, Hoofnagle AN, Szpiro A, Stern JE, et al
    Understanding the role of emerging vitamin D biomarkers on short-term persistence of high-risk HPV infection among mid-adult women.
    J Infect Dis. 2020 Nov 17. pii: 5986719. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. GAO L, Wang Z, van der Veen S
    Gonococcal adaptation to palmitic acid through farAB expression and FadD activity mutations increases in vivo fitness in a murine genital tract infection model.
    J Infect Dis. 2020 Nov 10. pii: 5973518. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. KAHLER CM
    The Goldilocks Zone: Searching for a Phylogenetic Approach for the Recombinogenic Neisseria gonorrhoeae.
    J Infect Dis. 2020;222:1762-1763.
    PubMed    
    
    
    
49. CEHOVIN A, Jolley KA, Maiden MCJ, Harrison OB, et al
    Association of Neisseria gonorrhoeae Plasmids With Distinct Lineages and The Economic Status of Their Country of Origin.
    J Infect Dis. 2020;222:1826-1836.
    PubMed     Abstract available
    
    
    
50. BETTAMPADI D, Dickey B, Abrahamsen M, Sirak B, et al
    Differences in factors associated with high and low risk oral HPV genotypes in men.
    J Infect Dis. 2020 Nov 5. pii: 5957070. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2020
51. PICKERING H, Chernet A, Sata E, Zerihun M, et al
    Genomics of Ocular Chlamydia trachomatis after 5 years of SAFE interventions for trachoma in Amhara, Ethiopia.
    J Infect Dis. 2020 Oct 9. pii: 5920008. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. KANN H, Lehtinen M, Eriksson T, Surcel HM, et al
    Sustained Cross-Reactive Antibody Responses After Human Papillomavirus Vaccinations: Up To 12 Years Follow-Up In The Finnish Maternity Cohort.
    J Infect Dis. 2020 Oct 3. pii: 5917504. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2020
53. TOTA JE, Struyf F, Hildesheim A, Gonzalez P, et al
    Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials.
    J Infect Dis. 2020 Sep 5. pii: 5901687. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. RENO H, Fox B, Highfill C, McKee A, et al
    The Emerging Intersection Between Injection Drug Use and Early Syphilis in Nonurban Areas of Missouri, 2012-2018.
    J Infect Dis. 2020;222.
    PubMed     Abstract available
    
    
    July 2020
55. CHEN W, Smajs D, Hu Y, Ke W, et al
    Analysis of Treponema pallidum strains from China using improved methods for whole-genome sequencing from primary syphilis chancres.
    J Infect Dis. 2020 Jul 25. pii: 5876405. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. GULATI S, Schoenhofen IC, Lindhout-Djukic T, Lewis LA, et al
    Efficacy of anti-gonococcal CMP-nonulosonate therapeutics require cathelicidins.
    J Infect Dis. 2020 Jul 21. pii: 5874433. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. SHAFER WM
    Drug targeting a gonococcal virulence factor exploits host antimicrobial peptides in clearance of infection.
    J Infect Dis. 2020 Jul 21. pii: 5874416. doi: 10.1093.
    PubMed    
    
    
    
58. HU SY, Tsang SH, Chen F, Pan QJ, et al
    Association between Common Vaginal Infections and Cervical Non-HPV16/18 Infection in HPV-Vaccinated Women.
    J Infect Dis. 2020 Jul 2. pii: 5866538. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2020
59. MEITES E, Winer RL, Newcomb ME, Gorbach PM, et al
    Vaccine effectiveness on DNA prevalence of human papillomavirus infection in anal and oral specimens from men who have sex with men- United States, 2016-2018.
    J Infect Dis. 2020 Jun 6. pii: 5854104. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2020
60. YUILL S, Egger S, Smith M, Velentzis L, et al
    Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia.
    J Infect Dis. 2020 May 9. pii: 5827184. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2020
61. CLIFFORD GM, Combes JD
    Hopes for Prevention of Anal Cancer in Women.
    J Infect Dis. 2020;221:1210-1212.
    PubMed    
    
    
    
62. KOJIMA N, Siebert JC, Maecker H, Rosenberg-Hasson Y, et al
    The application of cytokine expression assays to differentiate active from previously treated syphilis.
    J Infect Dis. 2020 Mar 19. pii: 5809968. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. HARRISON OB, Cehovin A, Skett J, Jolley KA, et al
    Neisseria gonorrhoeae Population Genomics: Use of the Gonococcal Core Genome to Improve Surveillance of Antimicrobial Resistance.
    J Infect Dis. 2020 Mar 12. pii: 5804212. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. DE SANJOSE S, Bruni L
    Is it now the time to plan for global gender-neutral vaccination?
    J Infect Dis. 2020 Mar 11. pii: 5803244. doi: 10.1093.
    PubMed    
    
    
    
65. VANSKA S, Luostarinen T, Bausssano I, Apter D, et al
    Vaccination with moderate coverage eradicates oncogenic human papillomaviruses if a gender-neutral strategy is applied.
    J Infect Dis. 2020 Mar 11. pii: 5803245. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2020
66. DENG X, Klausner JD
    Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae.
    J Infect Dis. 2020;221:851-852.
    PubMed    
    
    
    
67. THOMAS JC, Kersh EN, Gernert KM, Shafer WM, et al
    Reply: Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.
    J Infect Dis. 2020;221:852-853.
    PubMed    
    
    
    January 2020
68. CHEN NH, Ong CY, O'sullivan J, Ibranovic I, et al
    Two Distinct L-Lactate Dehydrogenases Play a Role in the Survival of Neisseria gonorrhoeae in Cervical Epithelial Cells.
    J Infect Dis. 2020;221:449-453.
    PubMed     Abstract available
    
    
    
69. HOES J, Pasmans H, Knol MJ, Donken R, et al
    Persisting Antibody Response Nine Years after Bivalent HPV Vaccination in A Cohort of Dutch Women: Immune Response and the Relation with Genital HPV Infections.
    J Infect Dis. 2020 Jan 9. pii: 5698719. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. JOHNSON RM, Olivares-Strank N, Peng G
    A class II-restricted CD813 T cell clone protects during Chlamydia muridarum genital tract infection.
    J Infect Dis. 2020 Jan 3. pii: 5695851. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2019
71. WIJERS JNAP, Dukers-Muijrers NHTM, van Liere GAFS, Dirks JAMC, et al
    Men and women have an equal oropharyngeal and anorectal Chlamydia trachomatis bacterial load: a comparison of three anatomic sites.
    J Infect Dis. 2019 Dec 16. pii: 5678512. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2019
72. MARKOWITZ LE, Naleway AL, Klein NP, Lewis RM, et al
    Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses.
    J Infect Dis. 2019 Nov 30. pii: 5648192. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. SEMCHENKO EA, Mubaiwa TD, Day CJ, Seib KL, et al
    The gonococcal Neisserial Heparin Binding Antigen (NHBA) is involved in microcolony formation and contributes to serum resistance and adherence to epithelial cells.
    J Infect Dis. 2019 Nov 27. pii: 5644429. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. ALBERTS CJ, Heard I, Canestri A, Marchand L, et al
    Incidence and clearance of anal HPV-16 and HPV-18 infection, and their determinants, among HIV-infected men who have sex with men in France.
    J Infect Dis. 2019 Nov 22. pii: 5637552. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2019
75. KARUNAKARAN KP, Yu H, Jiang X, Chan QWT, et al
    Discordance in the epithelial cell-dendritic cell MHC class II immunoproteome: implications for Chlamydia vaccine development.
    J Infect Dis. 2019 Oct 10. pii: 5585005. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. ELLSWORTH GB, Wilkin TJ
    Another Call for Widespread Human Papillomavirus Vaccination.
    J Infect Dis. 2019 Oct 5. pii: 5581839. doi: 10.1093.
    PubMed    
    
    
    
77. TAMARELLE J, Ma B, Gajer P, Humphrys MS, et al
    Non-optimal vaginal microbiota after azithromycin treatment for Chlamydia trachomatis infection.
    J Infect Dis. 2019 Oct 1. pii: 5579997. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2019
78. PATEL P, Bush T, Conley L, Unger ER, et al
    Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.
    J Infect Dis. 2019 Sep 19. pii: 5571724. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2019
79. DROPULIC LK, Oestreich MC, Pietz HL, Laing KJ, et al
    A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus 2 Vaccine, HSV529, in Adults With or Without HSV Infection.
    J Infect Dis. 2019 May 6. pii: 5486075. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2019
80. KELLER MJ, Huber A, Espinoza L, Serrano MG, et al
    Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome.
    J Infect Dis. 2019 Apr 27. pii: 5481045. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. WOESTENBERG PJ, King AJ, Van Benthem BHB, Leussink S, et al
    Bivalent Vaccine Effectiveness Against Anal Human Papillomavirus Positivity Among Female Sexually Transmitted Infection Clinic Visitors in the Netherlands.
    J Infect Dis. 2019 Apr 23. pii: 5476422. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. OLESEN SW, Grad YH
    Deciphering the impact of bystander selection for antibiotic resistance in Neisseria gonorrhoeae.
    J Infect Dis. 2019 Apr 8. pii: 5430789. doi: 10.1093.
    PubMed    
    
    
    
83. KENYON C, Buyze J, Spiteri G, Cole MJ, et al
    Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis.
    J Infect Dis. 2019 Apr 8. pii: 5430759. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2019
84. WINER RL, Gheit T, Feng Q, Stern JE, et al
    Prevalence and Correlates of beta- and gamma-Human Papillomavirus Detection in Oral Samples From Mid-Adult Women.
    J Infect Dis. 2019;219:1067-1075.
    PubMed     Abstract available
    
    
    February 2019
85. LEE NR, Winer RL, Cherne S, Noonan CJ, et al
    Human Papillomavirus Prevalence Among American Indian Women of the Great Plains.
    J Infect Dis. 2019;219:908-915.
    PubMed     Abstract available
    
    
    
86. STEBEN M
    A Very Common Intimate Concern: "Will My Genital Warts Ever Stop Recurring?"
    J Infect Dis. 2019;219:682-684.
    PubMed    
    
    
    
87. GIULIANO AR, Sirak B, Abrahamsen M, Silva RJC, et al
    Genital Wart Recurrence Among Men Residing in Brazil, Mexico, and the United States.
    J Infect Dis. 2019;219:703-710.
    PubMed     Abstract available
    
    
    
88. ROLLISON DE, Schell MJ, Fenske NA, Cherpelis B, et al
    Cutaneous Viral Infections Across 2 Anatomic Sites Among a Cohort of Patients Undergoing Skin Cancer Screening.
    J Infect Dis. 2019;219:711-722.
    PubMed     Abstract available
    
    
    
89. MARRAZZO JM, Rabe L, Kelly C, Richardson B, et al
    Tenofovir gel for prevention of herpes simplex virus type-2 acquisition: findings from the VOICE Trial.
    J Infect Dis. 2019 Feb 11. pii: 5315462. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2019
90. COHEN MS, Donnell D
    Novel approaches for development of HIV pre-exposure prophylaxis (PrEP) agents.
    J Infect Dis. 2019 Jan 31. pii: 5304967. doi: 10.1093.
    PubMed    
    
    
    
91. MULLICK C, Murray J
    Correlations between HIV infection and rectal gonorrhea incidence in men who have sex with men: Implications for future HIV pre-exposure prophylaxis trials.
    J Infect Dis. 2019 Jan 31. pii: 5304966. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. OLESEN SW, Torrone EA, Papp JR, Kirkcaldy RD, et al
    Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use.
    J Infect Dis. 2019;219:619-623.
    PubMed     Abstract available
    
    
    
93. GILKEY MB, Margolis MA
    Human Papillomavirus Vaccination Coverage Gaps in Young Adolescents.
    J Infect Dis. 2019 Jan 17. pii: 5265336. doi: 10.1093.
    PubMed    
    
    
    
94. BEDNARCZYK RA, Ellingson MK, Omer SB
    Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data.
    J Infect Dis. 2019 Jan 17. pii: 5265326. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. ZHAO X, Zhao S, Hu S, Zhao K, et al
    Role of Human Papillomavirus DNA Load in Predicting the Long-term Risk of Cervical Cancer: A 15-Year Prospective Cohort Study in China.
    J Infect Dis. 2019;219:215-222.
    PubMed     Abstract available
    
    
    
96. LU P, Wang S, Lu Y, Neculai D, et al
    A Subpopulation of Intracellular Neisseria gonorrhoeae Escapes Autophagy-Mediated Killing Inside Epithelial Cells.
    J Infect Dis. 2019;219:133-144.
    PubMed     Abstract available
    
    
    November 2018
97. MANN LM, Llata E, Flagg EW, Hong J, et al
    Trends of Anogenital Warts Among Sexually Transmitted Disease Clinic Patients - Sexually Transmitted Disease Surveillance Network, United States, 2010-2016.
    J Infect Dis. 2018 Nov 29. pii: 5219029. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2018
98. KUDO R, Yamaguchi M, Sekine M, Adachi S, et al
    Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection.
    J Infect Dis. 2018 Oct 9. pii: 5115492. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2018
99. MARRA E, Lin C, Clifford GM
    Type-specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: a systematic literature review and meta-analysis.
    J Infect Dis. 2018 Sep 20. pii: 5103515. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. ARTEMCHUK H, Eriksson T, Poljak M, Surcel HM, et al
     Long-Term Antibody Response to Human Papillomavirus Vaccines: up to 12 Years Follow-Up in the Finnish Maternity Cohort.
     J Infect Dis. 2018 Sep 18. pii: 5099444. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2018
101. PUDNEY J, Wangu Z, Panther L, Fugelso D, et al
     Condylomata acuminata (anogenital warts) contain accumulations of HIV-1 target cells that may provide portals for HIV transmission.
     J Infect Dis. 2018 Aug 18. pii: 5076076. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: